Li Can, Zhao Jiuliang, He Kun, Wu Yan, Liu Sheng, Wang Qian, Zhao Yan
Department of Rheumatology.
Department of Medicine, Peking Union Medical College Hospital.
Medicine (Baltimore). 2018 Oct;97(40):e12710. doi: 10.1097/MD.0000000000012710.
Chronic thromboembolic pulmonary hypertension (CTEPH) is a severe complication of antiphospholipid syndrome (APS). Once diagnosed, the recommendation for the treatment of CTEPH is long-term anticoagulation and pulmonary thromboendarterectomy (PTE). However, cardiac surgeons apply PTE cautiously for these patients, as there is an increased risk of perioperative complications. Here, we present the curative case of a patient with severe APS-associated CTEPH treated with PTE.
A 29-year-old man presented with chest pain, decreased exercise capacity, dyspnoea, and haemoptysis.
He was triple positive for antiphospholipid antibodies. Computed tomography pulmonary angiography revealed multiple, recurrent pulmonary embolisms and complete obstruction of the left pulmonary artery. He was diagnosed with APS and CTEPH.
After balancing the risk of thrombosis and haemorrhage, the patient underwent PTE.
The patient experienced symptom relief after PTE, and electrocardiography at a six-month follow-up showed a recovery of cardiac structure and pulmonary arterial pressure.
After evaluating the thrombosis risk at an experienced treatment centre and the application of standard anticoagulation treatment, PTE may be a curative resolution for APS-associated CTEPH.
慢性血栓栓塞性肺动脉高压(CTEPH)是抗磷脂综合征(APS)的一种严重并发症。一旦确诊,CTEPH的治疗建议是长期抗凝和肺动脉血栓内膜剥脱术(PTE)。然而,心脏外科医生对这些患者谨慎施行PTE,因为围手术期并发症风险增加。在此,我们展示一例接受PTE治疗的重度APS相关CTEPH患者的治愈病例。
一名29岁男性,出现胸痛、运动能力下降、呼吸困难和咯血症状。
抗磷脂抗体三项呈阳性。计算机断层扫描肺动脉造影显示多发、复发性肺栓塞以及左肺动脉完全阻塞。他被诊断为APS和CTEPH。
在权衡血栓形成和出血风险后,患者接受了PTE。
患者在PTE后症状缓解,六个月随访时心电图显示心脏结构和肺动脉压力恢复。
在经验丰富的治疗中心评估血栓形成风险并应用标准抗凝治疗后,PTE可能是APS相关CTEPH的一种治愈性解决方案。